期刊文献+

肠道病毒71型手足口病患者外周血淋巴细胞增殖反应 被引量:2

Peripheral Blood Lymphocyte Proliferation Response to Enterovirus 71(EV71) Antigens in HFMD Patients Infected With EV71
下载PDF
导出
摘要 目的研究肠道病毒71型(EV71)手足口病患者外周血淋巴细胞对不同EV71抗原刺激的增殖反应。方法将38例研究对象分为手足口病EV71阳性重症组8例、轻症组10例、EV71阴性组10例、健康对照组10例。外周血单核细胞(PBMC)与EV71合成多肽SP1、SP2、SP3、灭活EV71和植物血凝素(PHA)分别共同孵育,加入胸腺嘧啶核苷(3H-TdR),然后收集细胞于液闪仪测定每分钟脉冲数(cpm)。结果对不同EV71抗原的淋巴细胞增殖反应发现,以灭活病毒EV71免疫原性最强,SP2次之。EV71轻症和重症患者淋巴细胞增殖反应比较差异无统计学意义(P>0.05),EV71阴性手足口病患者及健康对照组对EV71抗原未能显示有效的淋巴细胞增殖反应。结论灭活EV71免疫原性最强,感染EV71的患者淋巴细胞对EV71抗原刺激呈特异性增殖反应。 Objective To investigate proliferation response of peripheral blood mononuclear cells ( PBMC ) of patients with HFMD infected with enterovirus 71 ( EV71 ) different EV71 antigens stimulation. Methods Peripheral blood mononudear cells ( PBMC ) were co - cultured with EV71 antigens peptide SP1, SP2, SP3, inactivated EV71 and phytohemagglutinin ( PHA ), respectively, thymidine ( 3 H - TdR ) was added and counts per minute ( epm ) were measured. Results Based on cpm, inactivate EVT1 is the strongest immunogenie antigen, followed by SP2. Lymphocyte activation between mild and severe EV71 have no significant differences( P 〉0.05 ) , and EV71 antigen stimulation had no effect on proliferation response in patients with HFMD uninfected with EV71 and the control group. Conclusion Inactivate EV71 is the most immunogenie antigen. Patients infected with EV71 have more specific lymphocyte proliferation response compared with controls and patients with EV71 infection.
出处 《南华大学学报(医学版)》 2010年第4期484-486,共3页 Journal of Nanhua University(Medical Edition)
关键词 肠道病毒71型 抗原 淋巴细胞 增殖反应 Enterovirus 71( EV71 ) antigens lymphocyte proliferation response
  • 相关文献

参考文献7

  • 1刘映霞,谢靖婧,何颜霞,刘威龙,张明霞,乐晓华,付丹,陈心春,杨桂林,操德智,张红梅,徐六妹,朱秀云,谭艳,杨倩婷,周伯平.轻型和重型手足口病临床和实验室特征分析[J].中华实验和临床病毒学杂志,2008,22(6):475-477. 被引量:47
  • 2Luo ST,Chiang PS,Chao AS,et al.Enterovirus 71 Maternal Antibodies in Infants,Taiwan[J].Emerging Infectious Diseases,2009,15 (4):581 -584.
  • 3Chang LY,Hsiung CA,Lu CY.Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71[J].Pediatr Res,2006,60 (4):466 -471.
  • 4Wu CN,Lin YC,Fann C,et al.Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus[J].Vaccine,2001,20(5):895 -904.
  • 5Chen HL,Huang JY,Chu TW,et al.Expression of VP1 protein in the milk of transgenic mice:a potential oral vaccine protects against enterovirus 71 nfection[J].Vaccine,2008,26(23):2882-2889.
  • 6Lin TY,Hsia SH,Huang YC,et al.Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system[J].Clin Infect Dis,2003,36 (3):269 -274.
  • 7Foo DG,Macary PA,Alonso S,et al.Identification of human CD4 T-cell epitopes on the VP1 capsid protein of enterovirus 71[J].Viral Immunol,2008,21 (2):215 -224.

二级参考文献4

  • 1Tu PV, Thao NT, Perera D, et al. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis, 2007,13 : 1733-1741.
  • 2Chang LY, Lee CY, Kao CL, et al. foot and mouth disease complicated with central nervous system involvement in Taiwan in 1980--1981. J Formos Med Assoc, 2007,106 : 173-176.
  • 3Shekhar K,Lye MS, Norlijah O, et al. Deaths in children during an outbreak of hand,foot and mouth disease in Peninsular Malaysia-- clinical and pathological characteristics. Med J Malaysia, 2005,60: 297-304.
  • 4张占卿.手足口病[J].世界感染杂志,2007,7(6):446-450. 被引量:43

共引文献46

同被引文献8

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部